July 9, 2026 · Form 4 insider transaction
Rodman David Malcom bought 2,171 shares of Mineralys Therapeutics, Inc. at $16.00 per share, a transaction worth $34.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.; This balance includes 638 shares purchased under the Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan that were not previously reported.